SGS implements Veeva Vault clinical trial management system across its global network

Will improve operational efficiency and drive faster, higher-quality trial execution.
SGS will implement the Veeva Vault CTMS (clinical trial management system) across its network of clinical operations sites for the management of its global clinical study services.
Vault CTMS will enable SGS to share state-of-the-art reporting capabilities with its clients and deliver greater flexibility in running studies. Together with Veeva Vault eTMF (electronic trial master file), SGS will drive greater harmonization across its clinical operations. SGS will begin running studies on Vault CTMS in spring 2019, with any current studies scheduled to end after June 2019 being migrated to the new system.
“Veeva Vault CTMS, along with Veeva Vault eTMF will allow us to streamline our clinical trial management and improve decision-making within our planning and operations teams across the Americas and Europe,” commented Janelle Johnson, SGS International Project Management Director. “SGS is committed to investing where necessary to maintain its leadership position in clinical research, and ensuring it has the most efficient systems, and in-turn, offer the highest level of service and experience to our clients.”
“Veeva Vault CTMS will enable SGS to improve its operational efficiency and drive faster, higher-quality trial execution,” added Henry Galio - Senior Director, Veeva Vault CTMS. Now clinicians and managers can have greater oversight and improved decision-making capabilities during studies”.

Related News
-
News 3 ways ChatGPT will impact pharma marketing teams
What does the rise of AI-powered chatbots such as ChatGPT and GPT-4 mean for pharma marketeers? -
News Eli Lilly, Novo Nordisk, and Sanofi cut insulin prices by up to 78%
Insulin prices have dropped in a stark play by the three biggest makers of the product, after calls from the top of the US government. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Open letter challenges EU Commission on medicine supply chain
In an open letter to the European Commission, Medicines for Europe calls for a new medicine security contract with their goal to improve access to medicine and ensure a secure supply chain to Europe. -
News The Biggest Drug Approvals of 2022
A carefully curated list of the most notable drug approvals of the past year, covering neurology, oncology, and COVID-19, as well as a look at the most promising drugs up for review in 2023. -
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance